Annual SG&A
$263.37M$44.78M+20.49%
Summary
- Current Value
- As of today, RGEN annual SG&A is $263.37M, up +20.49% on
- Historical Performance
- RGEN annual SG&A is up +43.24% over the past 3 years, and up +175.45% over the past 5 years
- All-Time High Comparison
- RGEN annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- RGEN annual SG&A is +22.03% above its 3-year low of $215.83M reached on an earlier date
- Sector Comparison
- RGEN annual SG&A is higher than 91.27% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $263.37M | +20.5% | +43.2% | +175.4% | +3624.2% | |
| Quarterly SG&A | $73.66M | -2.6% | +37.3% | +153.6% | +3963.9% | |
| TTM SG&A | $1.69B | +549.3% | +688.0% | +1416.2% | +10000.0% | |
| Price | $166.82 | +7.8% | +5.0% | -19.9% | +3717.4% | |
| Annual Operating Expenses | $306.57M | +17.3% | +40.5% | +166.4% | +1343.9% | |
| Annual Operating Profit | -$31.92M | -286.3% | -118.4% | -188.5% | -453.6% | |
| Annual D&A | $86.56M | +0.5% | +125.2% | +314.8% | +6177.2% | |
| Annual Revenue | $634.44M | +0.3% | -5.4% | +134.8% | +2925.3% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $263.37M | at high | |
| 5Y | $263.37M | at high | |
| All | $263.37M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $215.83M | N/A | +22.0% |
| 5Y | $119.62M | N/A | +120.2% |
| All | $1.30M | >+9999.0% |
SG&A History
FAQ
What is the current annual SG&A of RGEN?
As of today, RGEN annual SG&A is $263.37M
What is 1-year change in RGEN annual SG&A?
RGEN annual SG&A is up +20.49% year-over-year
What is 3-year change in RGEN annual SG&A?
RGEN annual SG&A is up +43.24% over the past 3 years
How far is RGEN annual SG&A from its all-time high?
RGEN annual SG&A is currently at its all-time high
How does RGEN annual SG&A rank versus sector peers?
RGEN annual SG&A is higher than 91.27% of companies in Healthcare sector
When is RGEN next annual earnings release?
The next annual earnings release for RGEN is on
Quarterly SG&A
$73.66M$2.44M+3.42%
Summary
- Current Value
- As of today, RGEN quarterly SG&A is $73.66M, up +3.42% on
- Historical Performance
- RGEN quarterly SG&A is down -2.58% year-over-year, and up +37.32% over the past 3 years
- All-Time High Comparison
- RGEN quarterly SG&A is currently -2.58% below its historical high of $75.61M set on
- 3-Year Low Comparison
- RGEN quarterly SG&A is +50.08% above its 3-year low of $49.08M reached on
- Sector Comparison
- RGEN quarterly SG&A is higher than 89.19% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $73.66M | +3.4% | -2.6% | +37.3% | +153.6% | |
| Annual SG&A | $263.37M | – | +20.5% | +43.2% | +175.4% | |
| TTM SG&A | $1.69B | +507.2% | +549.3% | +688.0% | +1416.2% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| Quarterly Operating Expenses | $75.84M | +1.7% | +1.6% | +73.0% | +133.5% | |
| Quarterly Operating Profit | $16.35M | +101.4% | +482.0% | -74.5% | -25.6% | |
| Quarterly D&A | $24.41M | -1.4% | +13.8% | +92.6% | +263.7% | |
| Quarterly Revenue | $188.81M | +3.5% | +21.9% | -6.0% | +100.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $73.66M | at high | |
| 3Y | $75.61M | -2.6% | |
| 5Y | $75.61M | -2.6% | |
| All | $75.61M | -2.6% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $60.47M | N/A | +21.8% |
| 3Y | $49.08M | +50.1% | |
| 5Y | $36.34M | N/A | +102.7% |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of RGEN?
As of today, RGEN quarterly SG&A is $73.66M
What is RGEN quarterly SG&A most recent change?
RGEN quarterly SG&A was up +3.42% on September 30, 2025
What is 1-year change in RGEN quarterly SG&A?
RGEN quarterly SG&A is down -2.58% year-over-year
How far is RGEN quarterly SG&A from its all-time high?
RGEN quarterly SG&A is currently -2.58% below its historical high of $75.61M set on September 30, 2024
How does RGEN quarterly SG&A rank versus sector peers?
RGEN quarterly SG&A is higher than 89.19% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
TTM SG&A
$1.69B$1.74M+0.10%
Summary
- Current Value
- As of today, RGEN TTM SG&A is $1.69B, up +0.10% on
- Historical Performance
- RGEN TTM SG&A is up +549.29% year-over-year, and up +688.05% over the past 3 years
- All-Time High Comparison
- RGEN TTM SG&A is currently -3.90% below its historical high of $1.76B set on an earlier date
- 3-Year Low Comparison
- RGEN TTM SG&A is +28.91% above its 3-year low of $1.31B reached on an earlier date
- Sector Comparison
- RGEN TTM SG&A is higher than 90.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $1.69B | +507.2% | +549.3% | +688.0% | +1416.2% | |
| Annual SG&A | $263.37M | – | +20.5% | +43.2% | +175.4% | |
| Quarterly SG&A | $73.66M | +3.4% | -2.6% | +37.3% | +153.6% | |
| Price | $166.82 | +12.1% | +7.8% | +5.0% | -19.9% | |
| TTM Operating Profit | $48.29M | +74.6% | +73.8% | -80.5% | -18.6% | |
| TTM D&A | $94.87M | +3.2% | +7.0% | +99.2% | +269.8% | |
| TTM Revenue | $707.89M | +5.0% | +11.7% | -11.7% | +116.4% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.73B | N/A | -2.0% |
| 3Y | $1.76B | N/A | -3.9% |
| 5Y | $1.76B | N/A | -3.9% |
| All | $1.76B | N/A | -3.9% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.69B | N/A | +0.1% |
| 3Y | $1.31B | N/A | +28.9% |
| 5Y | $159.02M | N/A | +963.8% |
| All | -$630.26M | N/A | +368.4% |
TTM SG&A History
FAQ
What is the current TTM SG&A of RGEN?
As of today, RGEN TTM SG&A is $1.69B
What is RGEN TTM SG&A most recent change?
RGEN TTM SG&A was up +0.10% on September 30, 2025
What is 1-year change in RGEN TTM SG&A?
RGEN TTM SG&A is up +549.29% year-over-year
How does RGEN TTM SG&A rank versus sector peers?
RGEN TTM SG&A is higher than 90.78% of companies in Healthcare sector
When is RGEN next earnings release?
The next earnings release for RGEN is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/730272/000119312525252385/0001193125-25-252385-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000095017025038999/0000950170-25-038999-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen